Showing results (81-90 of 97) with videos related to
Sort By:
Pageof 10
Journal of Immunology (Baltimore, Md. : 1950)|September 30, 2016
High Doses of GM-CSF Inhibit Antibody Responses in Rectal Secretions and Diminish Modified Vaccinia Ankara/Simian Immunodeficiency Virus Vaccine Protection in TRIM5α-Restrictive MacaquesSunil Kannanganat, Linda S Wyatt, Sailaja Gangadhara, et al.International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|January 4, 2023
Antibody response, neutralizing potency, and transplacental antibody transfer following SARS-CoV-2 infection versus mRNA-1273, BNT162b2 COVID-19 vaccination in pregnancyCarolynn M Dude, Naima T Joseph, Alexandra D Forrest, et al.Journal of Virology|May 22, 2002
Critical role for Env as well as Gag-Pol in control of a simian-human immunodeficiency virus 89.6P challenge by a DNA prime/recombinant modified vaccinia virus Ankara vaccineRama Rao Amara, James M Smith, Silvija I Staprans, et al.Journal of Virology|July 29, 2016
Virus-Like Particles Displaying Trimeric Simian Immunodeficiency Virus (SIV) Envelope gp160 Enhance the Breadth of DNA/Modified Vaccinia Virus Ankara SIV Vaccine-Induced Antibody Responses in Rhesus MacaquesSmita S Iyer, Sailaja Gangadhara, Blandine Victor, et al.JCI Insight|March 10, 2022
Lymph node CXCR5+ NK cells associate with control of chronic SHIV infectionSheikh Abdul Rahman, James M Billingsley, Ashish Arunkumar Sharma, et al.Plos Pathogens|December 2, 2025
Monocyte-eosinophil signaling axis promotes vaccine-mediated protection against SARS-CoV-2Kathryn M Moore, Stephanie L Foster, Meenakshi Kar, et al.Biorxiv : the Preprint Server for Biology|August 30, 2024
Eosinophils protect against SARS-CoV-2 following a vaccine breakthrough infectionKathryn M Moore, Stephanie L Foster, Meenakshi Kar, et al.Science Translational Medicine|November 22, 2019
Strong TH1-biased CD4 T cell responses are associated with diminished SIV vaccine efficacyVenkateswarlu Chamcha, Pradeep B J Reddy, Sunil Kannanganat, et al.Vaccine|June 23, 2011
Prime-boost vaccination with heterologous live vectors encoding SIV gag and multimeric HIV-1 gp160 protein: efficacy against repeated mucosal R5 clade C SHIV challengesSamir K Lakhashe, Vijayakumar Velu, Gaia Sciaranghella, et al.Vaccine|May 2, 2002
Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccineRama Rao Amara, Francois Villinger, John D Altman, et al.Pageof 10